All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-LA-ZP127 | Anti-Influenza(M1-58) (GILGFVFTL) TCR-Like Antibody (M1-D1), HLA-A*0201-Restricted | Human | M1-D1 | GILGFVFTL | HLA-A*0201 | |||
TCR-LA-ZP128 | Anti-Influenza(M1-58) (GILGFVFTL) TCR-Like Antibody (M1-G8), HLA-A*0201-Restricted | Human | M1-G8 | GILGFVFTL | HLA-A*0201 | |||
TCR-LA-ZP129 | Anti-Influenza(M1-58) (GILGFVFTL) TCR-Like Antibody (M1-D12), HLA-A*0201-Restricted | Human | M1-D12 | GILGFVFTL | HLA-A*0201 | |||
TCR-LA-ZP130 | Anti-Influenza(M1-58) (GILGFVFTL) TCR-Like Antibody (M1-A2), HLA-A*0201-Restricted | Human | M1-A2 | GILGFVFTL | HLA-A*0201 |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION